about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
4.50
-0.17
(-3.64%)
1.7M
XNAS Volume
XNAS 17 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Replimune Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..